The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy
Copyright © 2021 Xie, Wang, Gan, Tang, Kang and Zhu..
Tumor necrosis factor receptor-associated protein 1 (TRAP1), a member of the heat shock protein 90 (Hsp90) chaperone family, protects cells against oxidative stress and maintains mitochondrial integrity. To date, numerous studies have focused on understanding the relationship between aberrant TRAP1 expression and tumorigenesis. Mitochondrial TRAP1 is a key regulatory factor involved in metabolic reprogramming in tumor cells that favors the metabolic switch of tumor cells toward the Warburg phenotype. In addition, TRAP1 is involved in dual regulation of the mitochondrial apoptotic pathway and exerts an antiapoptotic effect on tumor cells. Furthermore, TRAP1 is involved in many cellular pathways by disrupting the cell cycle, increasing cell motility, and promoting tumor cell invasion and metastasis. Thus, TRAP1 is a very important therapeutic target, and treatment with TRAP1 inhibitors combined with chemotherapeutic agents may become a new therapeutic strategy for cancer. This review discusses the molecular mechanisms by which TRAP1 regulates tumor progression, considers its role in apoptosis, and summarizes recent advances in the development of selective, targeted TRAP1 and Hsp90 inhibitors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Frontiers in oncology - 10(2020) vom: 20., Seite 585047 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xie, Shulan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Apoptosis resistance |
---|
Anmerkungen: |
Date Revised 13.02.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fonc.2020.585047 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321351185 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM321351185 | ||
003 | DE-627 | ||
005 | 20231226202602.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fonc.2020.585047 |2 doi | |
028 | 5 | 2 | |a pubmed24n1071.xml |
035 | |a (DE-627)NLM321351185 | ||
035 | |a (NLM)33575209 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xie, Shulan |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.02.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2021 Xie, Wang, Gan, Tang, Kang and Zhu. | ||
520 | |a Tumor necrosis factor receptor-associated protein 1 (TRAP1), a member of the heat shock protein 90 (Hsp90) chaperone family, protects cells against oxidative stress and maintains mitochondrial integrity. To date, numerous studies have focused on understanding the relationship between aberrant TRAP1 expression and tumorigenesis. Mitochondrial TRAP1 is a key regulatory factor involved in metabolic reprogramming in tumor cells that favors the metabolic switch of tumor cells toward the Warburg phenotype. In addition, TRAP1 is involved in dual regulation of the mitochondrial apoptotic pathway and exerts an antiapoptotic effect on tumor cells. Furthermore, TRAP1 is involved in many cellular pathways by disrupting the cell cycle, increasing cell motility, and promoting tumor cell invasion and metastasis. Thus, TRAP1 is a very important therapeutic target, and treatment with TRAP1 inhibitors combined with chemotherapeutic agents may become a new therapeutic strategy for cancer. This review discusses the molecular mechanisms by which TRAP1 regulates tumor progression, considers its role in apoptosis, and summarizes recent advances in the development of selective, targeted TRAP1 and Hsp90 inhibitors | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a apoptosis resistance | |
650 | 4 | |a cancer therapy | |
650 | 4 | |a inhibitors | |
650 | 4 | |a metabolic reprogramming | |
650 | 4 | |a tumor necrosis factor receptor-associated protein 1 | |
650 | 4 | |a tumorigenesis | |
700 | 1 | |a Wang, Xuanwei |e verfasserin |4 aut | |
700 | 1 | |a Gan, Shuyuan |e verfasserin |4 aut | |
700 | 1 | |a Tang, Xiaodong |e verfasserin |4 aut | |
700 | 1 | |a Kang, Xianhui |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Shengmei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in oncology |d 2011 |g 10(2020) vom: 20., Seite 585047 |w (DE-627)NLM218189583 |x 2234-943X |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g day:20 |g pages:585047 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fonc.2020.585047 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |b 20 |h 585047 |